These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 12465010)
1. Expression of type 2 nitric oxide synthase and vascular endothelial growth factor in oral dysplasia. Brennan PA; Umar T; Wilson AW; Mellor TK J Oral Maxillofac Surg; 2002 Dec; 60(12):1455-60. PubMed ID: 12465010 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Marrogi AJ; Travis WD; Welsh JA; Khan MA; Rahim H; Tazelaar H; Pairolero P; Trastek V; Jett J; Caporaso NE; Liotta LA; Harris CC Clin Cancer Res; 2000 Dec; 6(12):4739-44. PubMed ID: 11156228 [TBL] [Abstract][Full Text] [Related]
3. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression. Shang ZJ; Li JR J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226 [TBL] [Abstract][Full Text] [Related]
4. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Ambs S; Merriam WG; Bennett WP; Felley-Bosco E; Ogunfusika MO; Oser SM; Klein S; Shields PG; Billiar TR; Harris CC Cancer Res; 1998 Jan; 58(2):334-41. PubMed ID: 9443414 [TBL] [Abstract][Full Text] [Related]
5. [Nitric oxide synthase and vascular endothelial growth factor expression in hepatocellular carcinoma and their relation to angiogenesis]. Wang L; Tang Z; Sun H Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):301-3. PubMed ID: 11778555 [TBL] [Abstract][Full Text] [Related]
6. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas. Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671 [TBL] [Abstract][Full Text] [Related]
7. Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III). Ludwig HC; Ahkavan-Shigari R; Rausch S; Schallock K; Quentin C; Ziegler D; Bockermann V; Markakis E Anticancer Res; 2000; 20(1A):305-10. PubMed ID: 10769672 [TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021 [TBL] [Abstract][Full Text] [Related]
9. [Expression of vascular endothelial growth factor in oral squamous cell carcinoma]. Chen J; Wen Y; Li L; Wang C Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Oct; 19(5):303-5, 308. PubMed ID: 12539486 [TBL] [Abstract][Full Text] [Related]
10. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677 [TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production. Konopka TE; Barker JE; Bamford TL; Guida E; Anderson RL; Stewart AG Cancer Res; 2001 Apr; 61(7):3182-7. PubMed ID: 11306506 [TBL] [Abstract][Full Text] [Related]
12. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Welsh SJ; Bellamy WT; Briehl MM; Powis G Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766 [TBL] [Abstract][Full Text] [Related]
13. [Relationship between expression of inducible nitric oxide synthase and of VEGF in oral carcinoma]. Zhao S; Liu Y; Ping F Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):461-3. PubMed ID: 11930727 [TBL] [Abstract][Full Text] [Related]
14. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer. Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025 [TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors. Lewy-Trenda I; Wierzchniewska-Ćawska A Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614 [TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas]. Xu H; Shi XP; Tang WP; Li LX Ai Zheng; 2002 Sep; 21(9):983-8. PubMed ID: 12508547 [TBL] [Abstract][Full Text] [Related]
17. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma]. Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105 [TBL] [Abstract][Full Text] [Related]
18. [Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance]. Liu DB; Chen KN; Cao XZ; Wang T Ai Zheng; 2002 Sep; 21(9):989-93. PubMed ID: 12508548 [TBL] [Abstract][Full Text] [Related]
19. [Expression of vascular endothelial growth factor and microvessel density in ovarian tumor]. Qi SY Ai Zheng; 2003 Mar; 22(3):320-3. PubMed ID: 12654197 [TBL] [Abstract][Full Text] [Related]
20. The role of vascular endothelial growth factor (VEGF) in oral dysplasia and oral squamous cell carcinoma. Johnstone S; Logan RM Oral Oncol; 2006 Apr; 42(4):337-42. PubMed ID: 16144770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]